Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
CLDI
$1.35
+1.89%
CLDI
· Calidi Biotherapeutics, Inc.
$1.35
+0.03 (+1.89%)
At close · Aug 31
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company estimates that based on the Company's liquidity resources, there is substantial doubt about the Company's ability to continue as a going concern within 12 months from the date of issuance of these unaudited condensed consolidated financial statements.”View the 10-Q filed Aug 13, 2026
Market Cap
$3.41M
Shares
2.58M
All earnings calls
Earnings call · FY2024 Q2
Calidi Biotherapeutics, Inc. (CLDI) Q2 2024 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Diluted EPS
-$268.00
Net income
-$5.77M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 14, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 13, 2024 · complete as-filed document